ADVERTISEMENT

Clinical Summary

New ESMO guidelines on hereditary breast-ovarian cancer syndrome

Miriam Davis, PhD   |   10 November 2022

Takeaway

  • The European Society for Medical Oncology (ESMO) issued new guidelines on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndrome (HBOC).
  • HBOC has both clinical and molecular definitions: it is clinically defined by family history criteria and molecularly defined by germline pathogenic variants.

Why this matters

  • Many women are...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right